Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19726 - 19750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Coumaphos	Experimental Vet Approved	LIF	3976	upregulated	Coumaphos results in increased expression of LIF mRNA	22q12.2	A20662
Coumaphos	Experimental Vet Approved	SLC7A11	23657	upregulated	Coumaphos results in increased expression of SLC7A11 mRNA	4q28.3	A20662
Creatine	Approved Investigational Nutraceutical	PPARGC1A	10891	upregulated	Creatine results in increased expression of PPARGC1A mRNA	4p15.2	A20470
Crizotinib	Approved Investigational	CD44	960	downregulated	crizotinib results in decreased expression of CD44 mRNA	11p13	A21775
Crizotinib	Approved Investigational	CYP3A4	1576	upregulated	crizotinib results in increased expression of CYP3A4 mRNA	7q22.1	A21776
Crizotinib	Approved Investigational	EPCAM	4072	downregulated	crizotinib results in decreased expression of EPCAM mRNA	2p21	A21775
Crizotinib	Approved Investigational	FADS2	9415	upregulated	crizotinib results in increased expression of FADS2 mRNA	11q12.2	A21777
Crizotinib	Approved Investigational	FASN	2194	upregulated	crizotinib results in increased expression of FASN mRNA	17q25.3	A21777
Crizotinib	Approved Investigational	HMGCR	3156	upregulated	crizotinib results in increased expression of HMGCR mRNA	5q13.3	A21777
Crizotinib	Approved Investigational	HMGCS1	3157	upregulated	crizotinib results in increased expression of HMGCS1 mRNA	5p12	A21777
Crizotinib	Approved Investigational	INSIG1	3638	upregulated	crizotinib results in increased expression of INSIG1 mRNA	7q36.3	A21777
Crizotinib	Approved Investigational	PROM1	8842	downregulated	crizotinib results in decreased expression of PROM1 mRNA	4p15.32	A21775
Crizotinib	Approved Investigational	SREBF2	6721	upregulated	crizotinib results in increased expression of SREBF2 mRNA	22q13.2	A21777
Cupric Chloride	Approved	AASDHPPT	60496	downregulated	cupric chloride results in decreased expression of AASDHPPT mRNA	11q22.3	A21778
Cupric Chloride	Approved	ABCF3	55324	upregulated	cupric chloride results in increased expression of ABCF3 mRNA	3q27.1	A21778
Cupric Chloride	Approved	ABHD4	63874	upregulated	cupric chloride results in increased expression of ABHD4 mRNA	14q11.2	A21778
Cupric Chloride	Approved	ADRM1	11047	upregulated	cupric chloride results in increased expression of ADRM1 mRNA	20q13.33	A21778
Cupric Chloride	Approved	AHSG	197	downregulated	cupric chloride results in decreased expression of AHSG mRNA	3q27.3	A21778
Cupric Chloride	Approved	ALDOA	226	upregulated	cupric chloride results in increased expression of ALDOA mRNA	16p11.2	A21778
Cupric Chloride	Approved	ANKRD1	27063	upregulated	cupric chloride results in increased expression of ANKRD1 mRNA	10q23.31	A21778
Cupric Chloride	Approved	ANPEP	290	downregulated	cupric chloride results in decreased expression of ANPEP mRNA	15q26.1	A21778
Cupric Chloride	Approved	BAG3	9531	upregulated	cupric chloride results in increased expression of BAG3 mRNA	10q26.11	A21778
Cupric Chloride	Approved	BID	637	upregulated	cupric chloride results in increased expression of BID mRNA	22q11.21	A21778
Cupric Chloride	Approved	BLVRB	645	upregulated	cupric chloride results in increased expression of BLVRB mRNA	19q13.2	A21778
Cupric Chloride	Approved	CD63	967	downregulated	cupric chloride results in decreased expression of CD63 mRNA	12q13.2	A21778

Displaying entries 19726 - 19750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability